1. A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma. Issue 10 (3rd October 2015) Authors: Wagner-Johnston, Nina D.; Goy, Andrè; Rodriguez, Maria A.; Ehmann, W. Christopher; Hamlin, Paul A.; Radford, John; Thieblemont, Catherine; Suh, Cheolwon; Sweetenham, John; Huang, Yifan; Sullivan, Sharon T.; Vandendries, Erik R.; Gisselbrecht, Christian Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗